Cargando…

Low density lipoprotein bionanoparticles: From cholesterol transport to delivery of anti-cancer drugs

In this review article, we highlight the importance of low-density lipoprotein (LDL) and its implications in the field of drug delivery to cancer cells. LDL is naturally occurring bionanoparticles (BNP) with a size of 18–25 nm. These BNPs specifically transport cholesterol to cells expressing the LD...

Descripción completa

Detalles Bibliográficos
Autores principales:	Harisa, Gamaleldin I., Alanazi, Fars K.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	2013
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4281595/ https://www.ncbi.nlm.nih.gov/pubmed/25561862 http://dx.doi.org/10.1016/j.jsps.2013.12.015

Ejemplares similares

Design and encapsulation of anticancer dual HSP27 and HER2 inhibitor into low density lipoprotein to target ovarian cancer cells
por: Alhadad, Laila J., et al.
Publicado: (2020)

Hybrid Lymphatic Drug Delivery Vehicles as a New Avenue for Targeted Therapy: Lymphatic Trafficking, Applications, Challenges, and Future Horizons
por: Harisa, Gamaleldin I., et al.
Publicado: (2023)

Crosstalk of low density lipoprotein and liposome as a paradigm for targeting of 5-fluorouracil into hepatic cells: cytotoxicity and liver deposition
por: Alanazi, Saleh A., et al.
Publicado: (2021)

The beneficial roles of Lupineus luteus and lifestyle changes in management of metabolic syndrome: A case study
por: Harisa, Gamaleldin I., et al.
Publicado: (2015)

Erythrocyte nanovesicles: Biogenesis, biological roles and therapeutic approach: Erythrocyte nanovesicles
por: Harisa, Gamaleldin I., et al.
Publicado: (2017)

PEGylated SLN as a Promising Approach for Lymphatic Delivery of Gefitinib to Lung Cancer
por: Sherif, Abdelrahman Y, et al.
Publicado: (2022)

Engineered Nanoscale Lipid-Based Formulation as Potential Enhancer of Gefitinib Lymphatic Delivery: Cytotoxicity and Apoptotic Studies Against the A549 Cell Line
por: Sherif, Abdelrahman Y., et al.
Publicado: (2022)

Developed simvastatin chitosan nanoparticles co-crosslinked with tripolyphosphate and chondroitin sulfate for ASGPR-mediated targeted HCC delivery with enhanced oral bioavailability
por: Faris, Tarek M., et al.
Publicado: (2020)

Pravastatin chitosan nanogels-loaded erythrocytes as a new delivery strategy for targeting liver cancer
por: Harisa, Gamaleldin I., et al.
Publicado: (2016)

Chitosan treatment abrogates hypercholesterolemia-induced erythrocyte’s arginase activation
por: Harisa, Gamaleldin I., et al.
Publicado: (2017)

Optimization of Gefitinib-Loaded Nanostructured Lipid Carrier as a Biomedical Tool in the Treatment of Metastatic Lung Cancer
por: Sherif, Abdelrahman Y., et al.
Publicado: (2023)

MEDI6012: Recombinant Human Lecithin Cholesterol Acyltransferase, High‐Density Lipoprotein, and Low‐Density Lipoprotein Receptor–Mediated Reverse Cholesterol Transport
por: George, Richard T., et al.
Publicado: (2021)

Inclisiran, Low-Density Lipoprotein Cholesterol and Lipoprotein (a)
por: Katsiki, Niki, et al.
Publicado: (2023)

Association of the Low-density Lipoprotein Cholesterol/High-density Lipoprotein Cholesterol Ratio with Glecaprevir-pibrentasvir Treatment
por: Akutsu, Noriyuki, et al.
Publicado: (2021)

Editorial for the Special Issue on “Micro- and Nanofluidics for Bionanoparticle Analysis”
por: Cheng, Xuanhong, et al.
Publicado: (2019)

Assessing the Accuracy of Estimated Lipoprotein(a) Cholesterol and Lipoprotein(a)‐Free Low‐Density Lipoprotein Cholesterol
por: Zheng, Weili, et al.
Publicado: (2022)

Assessment of serum levels of triglycerides, total cholesterol, high-density lipoprotein cholesterol, and low-density lipoprotein cholesterol in periodontitis patients
por: Penumarthy, Swati, et al.
Publicado: (2013)

Comparison of low-density lipoprotein cholesterol/high-density lipoprotein cholesterol and total cholesterol/high-density lipoprotein cholesterol for the prediction of thin-cap fibroatheroma determined by intravascular optical coherence tomography
por: WANG, Yao, et al.
Publicado: (2020)

Total cholesterol/high-density lipoprotein cholesterol and low-density lipoprotein cholesterol/high-density lipoprotein cholesterol as predictors of coronary artery calcification assessed by multidetector computed tomography coronary angiography
por: Elsadek Seaoud, Elshaimaa Aly M., et al.
Publicado: (2022)

Triglycerides, total cholesterol, high density lipoprotein cholesterol and low density lipoprotein cholesterol in rats exposed to premium motor spirit fumes
por: Aberare, Ogbevire L., et al.
Publicado: (2011)

Low‐Density Lipoprotein Cholesterol Corrected for Lipoprotein(a) Cholesterol, Risk Thresholds, and Cardiovascular Events
por: Willeit, Peter, et al.
Publicado: (2020)

Correlation of Friedewald's calculated low-density lipoprotein cholesterol levels with direct low-density lipoprotein cholesterol levels in a tertiary care hospital
por: Nanda, Sunil Kumar, et al.
Publicado: (2017)

Acrolein Impairs the Cholesterol Transport Functions of High Density Lipoproteins
por: Chadwick, Alexandra C., et al.
Publicado: (2015)

Low Density Lipoprotein-Cholesterol/High Density Lipoprotein-Cholesterol Ratio Predicts Plaque Vulnerability in Patients With Stable Angina
por: Kim, Jeong Hun, et al.
Publicado: (2012)

Non-high density lipoprotein cholesterol versus low density lipoprotein cholesterol as a discriminating factor for myocardial infarction
por: Sigdel, Manoj, et al.
Publicado: (2012)

Age and Cardiovascular Risk Attributable to Apolipoprotein B, Low‐Density Lipoprotein Cholesterol or Non‐High‐Density Lipoprotein Cholesterol
por: Sniderman, Allan D., et al.
Publicado: (2016)

Characterization of Human Erythrocytes as Potential Carrier for Pravastatin: An In Vitro Study
por: Harisa, Gamal El-din I., et al.
Publicado: (2011)

Association of the low-density lipoprotein cholesterol/high-density lipoprotein cholesterol ratio and concentrations of plasma lipids with high-density lipoprotein subclass distribution in the Chinese population
por: Tian, Li, et al.
Publicado: (2010)

High-density lipoprotein metabolism and reverse cholesterol transport: strategies for raising HDL cholesterol
por: Trajkovska, Katerina Tosheska, et al.
Publicado: (2017)

Of statins and low-density lipoprotein cholesterol, “fats” and fiction
por: Unnikrishnan, Ambika Gopalakrishnan, et al.
Publicado: (2016)

Visit-to-visit variability in low-density lipoprotein cholesterol
por: Sookaromdee, Pathum, et al.
Publicado: (2019)

Achievement of Low-Density Lipoprotein Cholesterol Targets in CKD
por: Massy, Ziad A., et al.
Publicado: (2019)

Low-Density Lipoprotein Cholesterol Is Associated With Insulin Secretion
por: Dannecker, Corinna, et al.
Publicado: (2021)

Low-Density Lipoprotein Cholesterol and Mortality in Peritoneal Dialysis
por: Wu, Xianfeng, et al.
Publicado: (2022)

The Association between the Triglyceride to High-density Lipoprotein Cholesterol Ratio and Low-density Lipoprotein Subclasses
por: Moriyama, Kengo
Publicado: (2020)

Cholesteryl ester transfer protein inhibitors: from high-density lipoprotein cholesterol to low-density lipoprotein cholesterol lowering agents?
por: Nurmohamed, Nick S, et al.
Publicado: (2021)

Evaluating bionanoparticle infused fungal metabolites as a novel antimicrobial agent
por: Rajpal, Kartikeya, et al.
Publicado: (2016)

Inhibition of Listeria monocytogenes by Phage Lytic Enzymes Displayed on Tailored Bionanoparticles
por: Stone, Edel, et al.
Publicado: (2022)

The role of remnant cholesterol beyond low-density lipoprotein cholesterol in diabetes mellitus
por: Hu, Xiangming, et al.
Publicado: (2022)

Why Should We Measure Low-Density Lipoprotein Cholesterol Directly? Comparison of Low-Density Lipoprotein Cholesterol Assessment by Friedewald Estimation, and Direct Measurement
por: Cohen, Hofit
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_js25dnbkc7q9jon1hc38acba3j